Fresenius SE Net Profit Margin 2016-2023 | FSNUY

Current and historical net profit margin for Fresenius SE (FSNUY) from 2016 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue. Fresenius SE net profit margin for the three months ending September 30, 2023 was .
Fresenius SE Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2023-09-30 $39.20B $0.27B 0.68%
2023-06-30 $43.73B $1.03B 2.36%
2023-03-31 $43.10B $1.35B 3.14%
2022-12-31 $43.03B $1.45B 3.36%
2022-09-30 $43.53B $1.77B 4.06%
2022-06-30 $43.99B $1.93B 4.39%
2022-03-31 $44.47B $2.09B 4.70%
2021-12-31 $44.39B $2.15B 4.85%
2021-09-30 $44.08B $2.07B 4.70%
2021-06-30 $43.51B $2.08B 4.79%
2021-03-31 $42.19B $1.97B 4.66%
2020-12-31 $41.44B $1.95B 4.71%
2020-09-30 $40.66B $2.03B 4.99%
2020-06-30 $40.06B $2.02B 5.05%
2020-03-31 $40.09B $2.10B 5.24%
2019-12-31 $39.66B $2.11B 5.32%
2019-09-30 $39.42B $2.12B 5.39%
2019-06-30 $39.12B $2.12B 5.41%
2019-03-31 $39.27B $2.37B 6.03%
2018-12-31 $39.60B $2.39B 6.04%
2018-09-30 $39.76B $2.41B 6.06%
2018-06-30 $39.98B $2.39B 5.97%
2018-03-31 $39.37B $2.10B 5.34%
2017-12-31 $38.30B $2.05B 5.35%
2017-09-30 $36.47B $1.93B 5.28%
2017-06-30 $34.84B $1.90B 5.46%
2017-03-31 $33.47B $1.85B 5.53%
2016-12-31 $32.18B $1.76B 5.48%
2016-09-30 $31.71B $1.68B 5.29%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.002B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $15.353B 15.87
DaVita (DVA) United States $12.299B 15.28
Elanco Animal Health (ELAN) United States $8.994B 23.33
Encompass Health (EHC) United States $8.506B 21.77
Chemed (CHE) United States $8.076B 25.03
Option Care Health (OPCH) United States $4.839B 18.32
RadNet (RDNT) United States $4.232B 88.12
Amedisys (AMED) United States $2.993B 21.20
Astrana Health (ASTH) United States $2.272B 30.72
LifeStance Health (LFST) United States $2.018B 0.00
Addus HomeCare (ADUS) United States $1.914B 27.38
U.S Physical Therapy (USPH) United States $1.400B 37.46
Pennant (PNTG) United States $0.662B 34.98
Aveanna Healthcare Holdings (AVAH) United States $0.491B 0.00
Atai Life Sciences (ATAI) Germany $0.223B 0.00
Daxor (DXR) United States $0.042B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.014B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00